Venus Remedies Limited (BOM:526953)

Venus Remedies Financials Overview

Financials in millions INR. Fiscal year is April - March.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue Revenue Growth	8,373	7,696	6,529	6,014	5,555	6,002
Revenue Growth	19.76%	17.88%	8.55%	8.27%	-7.44%	9.50%
Gross Profit Gross Profit Growth	4,389	3,803	2,728	2,451	2,226	2,132
Operating Income Operating Income Growth	1,503	1,239	550.12	336.65	282.13	290.43
Net Income Net Income Growth	1,217	1,028	453.15	284.91	265.66	407.24
Earnings Per Share EPS Growth	91.03	76.90	33.90	21.31	19.87	30.86
EPS Growth	72.93%	126.84%	59.08%	7.22%	-35.60%	-38.33%

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Investments Cash & Investments Growth	901.5	989.16	868.08	838.05	720.77	432.56
Total Debt Total Debt Growth	117.4	124.09	16.93	413.25	422.93	428.45
Net Cash (Debt) Net Cash Growth	784.1	865.06	851.16	424.8	297.84	4.11
Net Cash Growth	-64.58%	1.63%	100.37%	42.63%	7153.70%	-
Net Cash Per Share Net Cash Per Share Growth	58.66	64.72	63.68	31.78	22.28	0.31

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Cash Flow Operating Cash Flow Growth	1,009	1,558	864.42	372.85	366.27	411.02
Capital Expenditures CapEx Growth	-506.26	-376.56	-96.27	-93.18	-78.18	-137.08
Free Cash Flow Free Cash Flow Growth	502.96	1,181	768.15	279.67	288.09	273.94
Free Cash Flow Growth	-58.93%	53.77%	174.66%	-2.92%	5.17%	-77.93%

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Gross Margin	52.42%	49.42%	41.78%	40.75%	40.07%	35.52%
Operating Margin	17.95%	16.10%	8.43%	5.60%	5.08%	4.84%
Pretax Margin	18.94%	17.43%	11.00%	7.42%	6.83%	6.07%
Profit Margin	14.53%	13.36%	6.94%	4.74%	4.78%	6.78%
FCF Margin	6.01%	15.35%	11.77%	4.65%	5.19%	4.56%

Dividends

Chart

Fiscal Year	Current	FY 2026
Period Ending	Nov 7, 2026	Mar 31, 2026
Dividend Per Share Dividend Per Share Growth	10.000	10.000
Dividend Per Share Growth	0%	-
Dividend Yield	0.68%	1.21%

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 7, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	16.06	10.74	8.84	15.31	8.15	8.82
P/FCF Ratio	38.85	9.34	5.21	15.60	7.51	13.12
PS Ratio	2.33	1.43	0.61	0.73	0.39	0.60

Data Source: S&P Global Market Intelligence Last updated: Oct 26, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 6, 2026

Data Sources Report a data error